Search Results 251-260 of 21214 for Inhibition

  1. A Study to Evaluate the Activity of 2 Dose Levels of Imetelstat in Participants with Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated with Janus Kinase (JAK) Inhibitor - Mayo Clinic

    ... Inhibitor. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab Title ...

  2. A Study of Anterior Cruciate Ligament Injury and Rehabilitation - Mayo Clinic

    The purpose of this study is to establish arthrogenic muscle inhibition (AMI) as a neural mechanism by examining the bilateral neuromotor drive of thigh ...

  3. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression - Mayo Clinic

    A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian ...

  4. Toward regeneration: Joint repair plus joint cell reboot - Mayo Clinic

    ... inhibition. Potential future clinical uses for Phlpp inhibitors with posttraumatic OA. Dr. Westendorf hopes that in the future, the joint itself and the ...

  5. Tadalafil (oral route) - Side effects & dosage - Mayo Clinic

    Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. ... If you take tadalafil for pulmonary arterial hypertension, do not take ...

  6. Anti-interleukin-5 therapy for severe asthma: A new therapeutic option - Mayo Clinic

    Anti-interleukin-5 therapy is approved for patients with refractory asthma with an eosinophilic phenotype. The severe asthma care team at Mayo Clinic has ...

  7. Clinical trials - Oncology (Medical)

    ... inhibitor, crizotinib. After enrollment, patients will receive one cycle of Induction chemotherapy. Subsequent therapy will be based upon MIBG avidity and ...

  8. Dexlansoprazole (oral route) - Side effects & dosage - Mayo Clinic

    Dexlansoprazole is a proton pump inhibitor (PPI). It works by decreasing the amount of acid produced by the stomach. This medicine is available only with ...

  9. Enasidenib (oral route) - Side effects & dosage - Mayo Clinic

    Enasidenib is an isocitrate dehydrogenase-2 inhibitor. It works by blocking the enzyme isocitrate dehydrogenase which is needed by the cancer cells to grow ...

  10. Olanzapine and fluoxetine (oral route) - Side effects & dosage - Mayo Clinic

    Fluoxetine is an antidepressant and belongs to a group of medicines known as selective serotonin reuptake inhibitors (SSRIs). ... inhibitor and wait 5 ...